Biovie Inc., of Los Angeles, revised the terms of its upcoming IPO. The firm plans to raise $15 million by offering 1.3 million shares at a price of $11.44. Biovie intends to trade under the ticker BIVI. Thinkequity is the sole bookrunner on the deal, expected to price this week.